MS181 is a BMI1 and RING1B degrader with antiproliferative activity. MS181 induces degradation via an EED -, CRBN -, and ubiquitin-proteosome system-dependent pathway, with preferential targeting over PRC2 components. MS181 acts in VHL-defective cancer cells. MS181 serves as a chemical biology tool to study PRC1 roles in cancer . MS181 can be used for the research of myelogenous leukemia, renal cell carcinoma, metastatic prostate cancer , triple negative breast cancer . (Pink: E1/E2/E3 Enzyme ligand ( HY-158771 ); Blue: Cereblon ligand ( HY-41547 ); Black: linker).
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Blood Disease | Products > Disease Areas > Triple-Negative Breast Cancer | Products > Disease Areas > Metastatic Prostate Cancer | Products > Disease Areas > Acute Myeloid Leukemia | Products > Disease Areas > Renal Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > BMI1 | Products > Signaling Pathways > E1/E2/E3 Enzyme | Products > Signaling Pathways > HOXA
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。